Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Activated Akt Prevents Antitumor Activity of Gefitinib in Renal Cancer Cells
Urology, 07/29/09
Kuroda K et al. – Constitutively activated Akt might prevent the antitumor efficacy of gefitinib in renal cell carcinoma, and the therapeutic effectiveness of gefitinib might be improved by inhibiting Akt activation.
Related Articles
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
Cancer Chemotherapy and Pharmacology, 11/18/09
Relevance Score: 68%
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 68%
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 68%
Incidence of Cancer in Finnish Families with Clinically Aggressive and Nonaggressive Prostate Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 67%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 67%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on novel agents in renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09
Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: Is this an oncocytic variant of chromophobe renal cell carcinoma
Diagnostic Cytopathology, 12/08/09
Carcinoid tumor of the kidney: An unusual renal tumor
Indian Journal of Urology, 12/08/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients
Nephrology Dialysis Transplantation, 12/08/09
Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09
Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: An in vitro study
The International Journal of Artificial Organs, 12/07/09
Article Search
Sponsor


See Latest Articles


